Stay updated on SPL7013 Gel in BV Recurrence Prevention Clinical Trial
Sign up to get notified when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.

Latest updates to the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page
- Check5 days agoChange DetectedThe page’s displayed site revision changes from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the study results content with a standard access-denied message.SummaryDifference18%

- Check47 days agoChange DetectedRevision label updated from v3.6.5 to v3.6.6 to reflect a new build. This is a metadata update and does not modify the visible content or functionality of the page.SummaryDifference0.0%

- Check68 days agoChange DetectedA new page revision version was introduced (v3.6.5), replacing the previous revision (v3.6.4).SummaryDifference0.1%

- Check82 days agoChange DetectedThe page now shows Revision: v3.6.4 instead of v3.6.3, indicating a new page build. There are no changes to the study results content.SummaryDifference0.0%

- Check104 days agoChange Detected- The page now shows Revision: v3.6.3 replacing v3.6.2, indicating a deployment update. The study results content and layout remain unchanged.SummaryDifference0.0%

Stay in the know with updates to SPL7013 Gel in BV Recurrence Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SPL7013 Gel in BV Recurrence Prevention Clinical Trial page.